Andrographolide, a novel bioactive phytoconstituent encapsulated in sustained release biodegradable nanoparticles
by Bothiraja Chellampillai, Atmaram P. Pawar
International Journal of Nanotechnology (IJNT), Vol. 8, No. 8/9, 2011

Abstract: Polymeric nanoparticles are advantageous in cancer therapy as they improve the physicochemical properties of drugs and consequently their behaviour in-vitro and the bioavailability of drugs. Andrographolide is a bioactive phytoconstituent widely used in the treatment of various tumours. However, the clinical efficacy by oral administration is contrasted by its biopharmaceutical properties. Hence an alternative dosage form and route of administration is investigated in the present study to enhance its therapeutic efficacy. Sustained release injectable andrographolide-loaded biodegradable poly(ε-caprolactone) (PCL) nanoparticle suspension was prepared by a solvent displacement process using poly(ethylene oxide) -poly(propylene oxide)-poly(ethylene oxide) (PEO–PPO–PEO) triblock polymeric stabiliser (Pluronic® F-68/Pluronic® F-127). The nanoparticles were characterised in terms of particle size, encapsulation efficiency, zeta potential, surface morphology and crystallinity. In-vitro drug release studies were carried out in presence and absence of the enzyme Candida rugose lipase in phosphate-buffered saline (PBS, pH 7.4) at 37°C using the dialysis bag diffusion technique. The obtained suspended nanoparticles were spherical in shape with particle size of 226 ± 2 to 339 ± 5 nm and zeta potential −25.2 ± 1.6 to −27.7 ± 1.3 mV. Higher value of Q_25hr (cumulative percentage release at the end of 25 h) and lower values of t_50% and t_80% (time required for 50% and 80% w/w drug release) indicated the suitability of PCL nanoparticles in controlled release, which followed diffusion mechanism. The study suggested the applicability of PCL nanoparticles to improve the biopharmaceutical properties of phytoconstituents in cancer chemotherapy.

Online publication date: Fri, 22-Jul-2011

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Nanotechnology (IJNT):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com